Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nbr
    Junior Member
    • Oct 2009
    • 3

    #1

    Total reads in Illumina run

    Hi folks,

    I am new to high-throughput sequencing and my lab has generated ChIP-seq data using Illumina.
    Does anybody know why would the total number of reads vary from sample to sample? Our first runs yielded about 17M reads. The last time, 2 samples had a total of 25M reads (one was input/control and another a TF).
    Supposedly, the DNA concentrations are normalized for sequencing.
    However, we do know that the 2 samples with more reads had initially much more DNA, so it is very tempting to believe that the normalization done was not that good.
    Does anybody know of other reasons why one would obtain more reads in a lane?
    Thanks in advance!
  • james hadfield
    Moderator
    Cambridge, UK
    Community Forum
    • Feb 2008
    • 224

    #2
    Hi,
    The normalisation done before sequencing; i.e. quantitate each library and put it on a flowcell lane, is not completely straightforward. Cluster density is determined by the concentration of the library and the dilution performed on it to bring it down to around 10pM. If anything is not quite right then the actual concentration you end up with, and the clusters you see, will be different. This is why there is variation from lane to lane. On top of that there is also variation between flowcells in the amount of oligo available for sample hybridisation. If we run the same diluted PhiX on two different flow cells we get different cluster densities.

    If you got over 15M reads then whoever ran your samples did a good, certainly adequate, job. Getting 25M reads from a lane is great, I wish we could get that all the time as well. 24M is our current best.

    James.

    Comment

    • nbr
      Junior Member
      • Oct 2009
      • 3

      #3
      Thank you for the reply, James, it was very informative.

      Although we got many more reads in those 2 samples, we obtained 25% and 36% (input) of uniquely aligned reads. The other 2 samples that had total number of reads around 10M had 38% (TF) and 40% (histone marker) uniquely aligned reads.

      The sample that yielded 25% seems to be a failed IP, or more likely, a bad antibody.
      I wonder if this would be an explanation for the lower % of alignable reads and if not, what is possible to do to obtain higher numbers of uniquely aligned reads (specially on the IP end versus the sequencing end, to which protocol we do not have access).
      Is it just a sample quality issue, or library construction can also be a major difference?

      Thank you very much!

      Comment

      • der_eiskern
        Member
        • Jul 2009
        • 46

        #4
        Originally posted by james hadfield View Post
        Hi,
        The normalisation done before sequencing; i.e. quantitate each library and put it on a flowcell lane, is not completely straightforward. Cluster density is determined by the concentration of the library and the dilution performed on it to bring it down to around 10pM. If anything is not quite right then the actual concentration you end up with, and the clusters you see, will be different. This is why there is variation from lane to lane. On top of that there is also variation between flowcells in the amount of oligo available for sample hybridisation. If we run the same diluted PhiX on two different flow cells we get different cluster densities.

        If you got over 15M reads then whoever ran your samples did a good, certainly adequate, job. Getting 25M reads from a lane is great, I wish we could get that all the time as well. 24M is our current best.

        James.
        James, is your 24M current best from a single lane before or after passing filter? Just want to make sure I'm not comparing apples and oranges (i got between 20 and 27M before filtering with on average 70% of the reads passing filter.--14M-18M PF)

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Working...